Table 1.
miR-363 expression and clinicopathological features in 49 osteosarcoma
| Clinicopathological features | Cases (n = 49) | miR-363 expression | P value* | |
|---|---|---|---|---|
| 23 high (%) | 26 low (%) | |||
| Gender | ||||
| Male | 25 | 12 (48.0) | 13 (52.0) | 0.879 |
| Female | 24 | 11 (45.8) | 13 (51.2) | |
| Age (years) | ||||
| ≤ 18 | 21 | 13 (61.9) | 8 (38.1) | 0.124 |
| > 18 | 28 | 10 (35.7) | 18 (64.3) | |
| Tumor size (mm) | ||||
| ≤ 5.0 | 22 | 14 (63.6) | 8 (36.4) | 0.035* |
| > 5.0 | 27 | 9 (33.3) | 18 (66.7) | |
| TNM stage | ||||
| I–II | 24 | 15 (62.5) | 9 (37.5) | 0.032* |
| III–IV | 25 | 8 (32.0) | 17 (68.0) | |
| Lymph node metastasis | ||||
| 0–2 | 28 | 17 (60.7) | 11 (39.3) | 0.026* |
| > 2 | 21 | 6 (28.6) | 15 (71.4) | |
| Metastasis | ||||
| Absent | 23 | 14 (60.9) | 9 (39.1) | 0.066 |
| Present | 26 | 9 (34.6) | 17 (65.4) | |
| NOB1 | ||||
| Low expression | 23 | 8 (34.8) | 15 (65.2) | 0.011* |
| High expression | 26 | 15 (57.7) | 11 (42.3) | |
*P values are calculated with chi-square test